Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, ...

The global longevity biotech market exploded from $27.15 billion in 2024 toward $46.61 billion by 2033 at 6.5% CAGR [1], as the $101 million XPRIZE Healthspan competition awarded milestone prizes to ...

With superior reactivity and stability, nanocatalysts are transforming catalytic processes, driving advancements in green ...

Inherited metabolic diseases are rare monogenic conditions that disrupt biochemical pathways, affecting energy production and ...

The global longevity biotech market exploded to $27.15 billion in 2024 and racing toward $46.61 billion by 2033 at a ...

Leapmotor Lafa5 Declaration Information Exposed, High Performance and Innovative Design Generate Expectations. Leapmotor once ...

Regulatory Milestone Underscores Continued Promise of First-in-Class Mitochondrial Cell TherapyHAIFA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), ...

If you're interested in starting to earn points or miles and enjoying a range of redemption options, there are plenty of travel rewards credit cards to choose from, each with its ...

Including Devialet's "Ultimate" wireless speaker, a classic bookshelf speaker reimagined and Garmin's latest smartwatch.